🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 3 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/10/2014 99,55 107,51 99,03 104,43 +1,59% 8,52% 615.300
15/10/2014 97,32 103,33 95,51 102,80 +3,45% 8,04% 669.500
14/10/2014 95,64 102,00 94,57 99,37 +5,51% 7,77% 756.700
13/10/2014 95,37 97,06 90,50 94,18 -0,75% 6,88% 498.200
10/10/2014 94,87 98,36 92,85 94,89 -0,70% 5,81% 438.800
09/10/2014 100,96 101,45 95,00 95,56 -5,69% 6,39% 467.200
08/10/2014 97,15 101,43 94,91 101,33 +3,87% 6,71% 415.200
07/10/2014 97,69 98,93 96,40 97,55 -0,81% 2,59% 321.300
06/10/2014 100,27 100,50 97,93 98,35 -2,01% 2,56% 574.600
03/10/2014 98,05 100,87 97,78 100,37 +3,05% 3,15% 541.000
02/10/2014 95,47 97,55 93,73 97,40 +1,81% 4,00% 363.200
01/10/2014 97,07 97,08 93,49 95,67 -1,29% 3,70% 474.200
30/09/2014 99,16 100,19 96,87 96,92 -2,26% 3,35% 537.400
29/09/2014 96,40 100,26 96,25 99,16 +1,18% 4,16% 508.400
26/09/2014 94,69 99,67 92,74 98,00 +3,57% 7,32% 932.900
25/09/2014 98,80 103,00 93,95 94,62 -10,97% 9,16% 2.380.000
24/09/2014 102,99 106,50 102,18 106,28 +5,02% 4,19% 586.500
23/09/2014 103,07 105,69 101,14 101,20 -2,81% 4,41% 544.600
22/09/2014 100,63 104,30 100,02 104,13 +2,92% 4,25% 445.300
19/09/2014 105,45 106,59 100,91 101,18 -3,87% 5,39% 708.000
18/09/2014 103,77 107,69 102,23 105,25 +2,03% 5,26% 384.600
17/09/2014 102,25 104,18 100,97 103,16 +1,29% 3,14% 245.600
16/09/2014 99,16 102,23 98,06 101,85 +2,25% 4,21% 405.400
15/09/2014 103,86 104,30 99,60 99,61 -4,42% 4,53% 401.600
12/09/2014 103,38 105,58 102,76 104,22 +0,96% 2,73% 492.800
11/09/2014 102,35 103,46 100,04 103,23 +0,36% 3,34% 382.900
10/09/2014 102,95 103,73 102,27 102,86 +0,50% 1,42% 348.600
09/09/2014 104,13 104,54 102,11 102,35 -1,72% 2,33% 209.100
08/09/2014 102,36 104,33 101,65 104,14 +1,74% 2,62% 217.900
05/09/2014 100,58 102,75 99,22 102,36 +1,10% 3,51% 359.300